Back to search

Marshall University

Thymidine phosphorylase is a promising target in SARS-CoV-2 spike protein-enhanced thrombosis

Abstract

dc:description.abstract

Thrombosis, as an underlying mechanism in cardiovascular diseases, is the leading global cause of death in the 21st century. Infection is a risk factor for thrombosis, and the coronavirus disease 2019 (COVID-19) pandemic has led to a rise in the incidence of thrombosis, thereby increasing mortality. In comparison to previous severe coronavirus outbreaks, rates of thrombosis in COVID-19 have been unprecedented. COVID-19 is caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 spike protein (SP), the key used to enter host cells, is implicated in thrombosis pathology, though mechanisms are not fully understood. The SARS-CoV-2 SP may also be involved in vaccine-induced immune thrombotic thrombocytopenia (VITT), a reaction to COVID-19 vaccination where deadly thromboses materialize. Discovering mechanism-based therapies for life-threatening diseases is paramount in minimizing off-target effects and maximizing positive responses to treatment. Thymidine phosphorylase (TYMP), a pyrimidine salvage pathway enzyme with novel prothrombotic function, has been identified by our lab as a target in COVID-19-associated thrombosis. This dissertation investigates SARS-CoV-2 SP-associated thrombosis using animal models, human tissue, blood studies, cell culture, and in-silico modeling, and shows the effectiveness of targeting TYMP to attenuate SP-promoted thrombosis. This dissertation aims to address knowledge gaps concerning the mechanistic impact of SP on thrombosis, establish a foundation for targeting TYMP as a potential therapeutic avenue, and unveil a novel interaction between SP and platelet factor 4 (PF4), which may bear implications for COVID-19-associated thrombosis and/or VITT.

Degree

thesis:*
Name thesis:degree_name
Biomedical Research
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Joan C. Edwards School of Medicine

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Roytenberg, Renat
Contributors dc:contributor
  • Dr. Wei Li, Committee Chairperson
  • Dr. Ji Bihl
  • Dr. Adolfo Garcia-Sastre

Subjects

dc:subject × 9

Identifiers

dc:identifier.*
Repository record dc:identifier
https://mds.marshall.edu/etd/1889

Chain of custody

source
Harvested from
Marshall University
Base URL
mds.marshall.edu/do/oai/
Last updated
2026-11-21
Source record
OAI-PMH GetRecord
citation

Roytenberg, Renat. Thymidine phosphorylase is a promising target in SARS-CoV-2 spike protein-enhanced thrombosis. Dissertation thesis, https://mds.marshall.edu/etd/1889